Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia

NCT00103727 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

282

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Talnetant
OTHER: placebo
OTHER: risperidone

Sponsor

GlaxoSmithKline